Publication

Determinants of Patient and Surrogate Experiences With Acute Care Research Consent: A Key Informant Interview Study

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Victoria M. Scicluna, University of MichiganSara F. Goldkind, Goldkind Consulting LLCAndrea R. Mitchell, Emory UniversityRebecca Pentz, Emory UniversityCandace D. Speight, Emory UniversityRobert Silbergleit, University of MichiganNeal Dickert, Emory University
Language
  • English
Date
  • 2019-11-19
Publisher
  • WILEY
Publication Version
Copyright Statement
  • © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 8
Issue
  • 22
Start Page
  • e012599
End Page
  • e012599
Grant/Funding Information
  • Research reported here was funded through a Patient‐Centered Outcomes Research Institute (PCORI) Award (ME‐1402‐10638).
Supplemental Material (URL)
Abstract
  • Background: Informed consent for acute myocardial infarction and stroke research is challenging. Time for enrollment decisions is limited, patients and family are usually stressed, and being asked to participate in research is often unexpected. Despite these barriers, patients and surrogates have reported a preference for prospective involvement in research decisions and generally positive views of the consent process. It is unknown what drives positive or negative consent experiences. These data are crucial to making consent processes more context appropriate. Methods and Results: We conducted a qualitative interview study with 27 patients and surrogates enrolled in acute myocardial infarction and stroke trials in the past 5 years. Purposive sampling from the P-CARE (Patient-Centered Approaches to Research Enrollment) study was based on participant characteristics and responses to initial patient-centered interviews. In-depth interviews used open-ended questions to explore factors influencing consent experiences. Qualitative descriptive analysis was performed utilizing a multilevel coding strategy. Participants identified specific researcher behaviors as important, including expressions of respect, professionalism, and nonpressuring communication. Participants preferred consent conversations focused on risks/benefits and the trial protocol. They had varying views of consent forms and communicated several reasons the form was valuable unrelated to informational content. Participants also valued postenrollment interactions as opportunities to ask questions and learn about the study. Conclusions: Barriers to consent in acute myocardial infarction and stroke trials are unavoidable, but participants identified productive ways to demonstrate respect for patients during enrollment conversations. These include key researcher behaviors, concentrating consent discussions on what participants find most important, and structured postenrollment follow-up.
Author Notes
  • Correspondence to: Victoria M. Scicluna, MD, MPH, University of Michigan, Department of Internal Medicine, 3116 Taubman Center, SPC 5368, 1500 E Medical Center Drive, Ann Arbor, MI 48109‐5368. E‐mail: vmah@med.umich.edu
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items